Advocate’s Corner: January 2024
Welcome to OCRA’s Advocate’s Corner, a new monthly series to keep you updated on how our Advocate Leaders and policy team are working on behalf of the ovarian and gynecologic … Continued
News
OCRA Celebrates Landmark Year of Achievements in 2023, Surpassing Fundraising Goals and Accelerating Research in Gynecologic Cancers
[New York, NY January 17, 2024] – Ovarian Cancer Research Alliance (OCRA) proudly announces the successful culmination of an extraordinary year, marking 2023 as a milestone in our pursuit of … Continued
Jasmine Plummer, PhD | Meet a Scientist
Dr. Jasmine Plummer of St. Jude Children’s Research Hospital (formerly of Cedars-Sinai Medical Center) is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded project is focused on better understanding … Continued
OCRA’s President & CEO Audra Moran Discusses Data & AI in Ovarian Cancer Research
In an interview for the podcast Overlooked, OCRA’s President & CEO Audra Moran talked about the future of ovarian cancer research, and how Ovarian Cancer Research Alliance is harnessing the … Continued
Maria Victoria Botuyan, PhD | Meet a Scientist
Dr. Maria Victoria Botuyan of Mayo Clinic Rochester is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded research is focused on studying how several proteins function together … Continued
Making a Difference One Dress at a Time | OCRA Heroes
Many brides count their wedding day as one of the most momentous occasions in their life. And now they have a way to make this milestone even more meaningful long … Continued
The Overview: December 2023
We took meaningful steps in the fight against ovarian and related gynecologic cancers this year, and we couldn’t have done it without your support. Join me for a look at … Continued
OCRA-Funded Researchers Make Breakthrough Toward Decreasing Chemoresistance
Snap Summary: OCRA-funded researchers discovered a potential key to reducing chemotherapy resistance, and reducing recurrence rates for the most common type of ovarian cancer. A research team at Magee-Women’s Research … Continued
OCRA-Funded Research Identifies Key Molecule with Immunotherapy Potential
Snap Summary: New findings could help develop better immune therapy for patients with the most common and lethal subtype of ovarian cancer. A recent study co-authored by Dr. Sherry Wu … Continued
The Overview: November 2023
OCRA’s Fall Advocacy Day Drives Change A sea of teal washed over the Capitol when more than 70 advocates from 30 states met with over 120 Congressional offices to push … Continued
OCRA’s Advocacy Day Media Coverage
The voices of OCRA’s advocates were amplified by recent television coverage of this year’s Fall Advocacy Day, during which more than 70 people from 30 states met with over 120 Congressional offices … Continued
OCRA’s Sarah DeFeo Receives Andrew Godwin Award for Excellence in Community Outreach
We are pleased to announce that OCRA’s Chief Program Officer, Sarah DeFeo, has been awarded the inaugural Andrew Godwin Award for Excellence in Community Outreach. Presented by Ovarian Cancer Midwest … Continued